Minshall, M. E., Oglesby, A. K., Wintle, M. E., Valentine, W. J., Roze, S., & Palmer, A. J. (2008). Estimating the Long-Term Cost-Effectiveness of Exenatide in the United States: An Adjunctive Treatment for Type 2 Diabetes Mellitus. Value in health, 11(1), 22-33. https://doi.org/10.1111/j.1524-4733.2007.00211.x
Chicago-Zitierstil (17. Ausg.)Minshall, Michael E., Alan K. Oglesby, Matthew E. Wintle, William J. Valentine, Stéphane Roze, und Andrew J. Palmer. "Estimating the Long-Term Cost-Effectiveness of Exenatide in the United States: An Adjunctive Treatment for Type 2 Diabetes Mellitus." Value in Health 11, no. 1 (2008): 22-33. https://doi.org/10.1111/j.1524-4733.2007.00211.x.
MLA-Zitierstil (9. Ausg.)Minshall, Michael E., et al. "Estimating the Long-Term Cost-Effectiveness of Exenatide in the United States: An Adjunctive Treatment for Type 2 Diabetes Mellitus." Value in Health, vol. 11, no. 1, 2008, pp. 22-33, https://doi.org/10.1111/j.1524-4733.2007.00211.x.